Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...
Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Looking ahead, revenue ...
Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.
The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.
The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...